Apollo Medical Holdings, Inc. to Present at Upcoming Investor Conferences
ALHAMBRA, Calif., May 11, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that Brandon Sim, Co-Chief Executive Officer, is scheduled to present at the following events in New York:
2022 RBC Capital Markets Global Healthcare Conference
Date: Wednesday, May 18, 2022, at 11:35 a.m. PT/2:35 p.m. ET
Venue: InterContinental New York Barclay
UBS Global Healthcare Conference 2022
Date: Monday, May 23, 2022, at 11 a.m. PT/2 p.m. ET
Venue: Lotte New York Palace
Management will also be participating in one-on-one meetings at these events. The Company's presentations will be made available via live webcast and in archive following the conclusion of the events at the "Events" page of the Company's website: https://www.apollomed.net/news-media/events.
ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.
Carolyne Sohn, The Equity Group
View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-to-present-at-upcoming-investor-conferences-301544648.html
SOURCE Apollo Medical Holdings, Inc.
Released May 11, 2022